Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 1

Status

Active not recruiting 2Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 2NIH 2NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Carcinoma, Hepatocellular 47Liver Neoplasms 22Stomach Neoplasms 11Neoplasm Metastasis 9Colorectal Neoplasms 9Sarcoma 6Pancreatic Neoplasms 6Neoplasms 6Colonic Neoplasms 6Breast Neoplasms 6Ovarian Neoplasms 5Hepatoblastoma 5Rectal Neoplasms 3Prostatic Neoplasms 3Peritoneal Neoplasms 3Lymphoma, Non-Hodgkin 3Appendiceal Neoplasms 3Uterine Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Multiple Myeloma 2Mesothelioma, Malignant 2Lung Neoplasms 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Myeloid, Acute 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Lymphocytic, Chronic, B-Cell 2

Interventions

Cisplatin 8Carboplatin 8X-Rays 7Specimen Handling 7Phantoms, Imaging 7Magnetic Resonance Spectroscopy 6Cyclophosphamide 6sodium thiosulfate 5Vincristine 5Nuclear Medicine Department, Hospital 5Granulocyte Colony-Stimulating Factor 5Etoposide 5Doxorubicin 5Biopsy 5Melphalan 4Irinotecan 4Fluorouracil 4fludarabine 3Thiotepa 3Oxaliplatin 3Mesna 3Gemcitabine 3Filgrastim 3Busulfan 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2pembrolizumab 2palbociclib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Hepatoblastoma × Doxorubicin × Gastrointestinal × Clear all
NCT03017326 2026-05-13

PHITT

University of Birmingham

Phase 3 Active not recruiting
450 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Hepatoblastoma

NCT04478292 2026-05-04

A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy

Shanghai Children's Medical Center

Phase 3 Recruiting
330 enrolled
Gastrointestinal

Hepatoblastoma

NCT03533582 2025-12-22

Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery

Children's Oncology Group

Phase 3 Active not recruiting
537 enrolled
Gastrointestinal

Fibrolamellar hepatocellular carcinoma, Hepatoblastoma

NCT00077389 2014-06-24

Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma

National Cancer Institute (NCI)

Phase 2 Unknown
57 enrolled
Gastrointestinal

Liver Neoplasms, Hepatoblastoma

NCT00003912 2013-12-04

Chemotherapy in Treating Children With Liver Cancer

National Cancer Institute (NCI)

Phase 3 Completed
260 enrolled
Gastrointestinal

Liver Neoplasms, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡